Patent Drawings for Investors: 7 Critical Diligence Checks

Most diligence memos count patents. Almost none of them open the figures. That is a mistake, because patent drawings for investors are the fastest honest read available on a young portfolio: they show whether the claims are actually supported, whether the file is going to sit in a formalities queue for another six months, and, in a design portfolio, exactly how much of the product the company owns. A drawing set takes twenty minutes to review and it does not spin. Here are the seven checks we run, the rules behind each one, and what a failure actually costs.

What Patent Drawings for Investors Actually Reveal

A claim set can be drafted broadly and still be worthless. A drawing set cannot bluff. The figures were filed on a date, they are fixed in the record, and every later amendment is measured against them. That is why patent drawings for investors carry diagnostic weight out of proportion to the attention they get.

Three things make them useful in diligence. First, they are cheap to review — you do not need to parse claim language to see that a claimed subsystem never appears in a figure. Second, they are objective; formalities either comply with the rules or they do not. Third, drawing problems are leading indicators. A file with a drawing objection outstanding is a file that is not going to issue on the timeline in the company’s model.

• Support risk — whether the specification can carry the claims it needs to carry
• Timing risk — whether formalities objections are sitting between the company and a grant
• Scope risk — in design filings, how much of the product is actually claimed
• Foreign-filing risk — whether the same figures survive an EPO or PCT filing without rework
• Process quality — whether counsel is running a repeatable prosecution process or improvising

None of that appears on a patent-count slide. All of it appears in the figures.

Check 1: Every Claimed Feature Has to Appear in a Figure

Start with the rule that does the most work. Under 37 CFR 1.83(a), the drawing in a nonprovisional application must show every feature of the invention specified in the claims. It is not a style preference. If a claim recites a component and no figure shows it, the examiner can object and require a new or amended sheet.

The check is mechanical. Take the independent claims, list the recited elements, and tick each one off against the figures and the reference numerals. When a startup has been amending claims through prosecution — adding a limitation to get around prior art — this is where the seams show. New limitations get argued into the claims and nobody goes back to the drawings.

Reviewing patent drawings for investors this way takes about fifteen minutes per family and it surfaces the single most common defect in early-stage files. If you want the mechanics of how numerals are supposed to behave across a figure set, our guide to patent drawing reference numerals covers the consistency rules examiners actually apply.

A miss here is usually fixable. But fixable means an office action, a response, and months — and it means the company’s issuance forecast is wrong.

Check 2: Formal Compliance Under 37 CFR 1.84

37 CFR 1.84 is the standard for drawings, and it is unusually specific. The provisions that catch real files:

• 1.84(a)(1) — India ink, or an equivalent that secures solid black lines, for black-ink drawings
• 1.84(f) — sheets must be A4 (21.0 by 29.7 cm) or 21.6 by 27.9 cm (8½ by 11 inches), and consistent across the application
• 1.84(g) — minimum margins of 2.5 cm top, 2.5 cm left, 1.5 cm right and 1.0 cm bottom
• 1.84(l) — every line, number and letter must be durable, clean, black, sufficiently dense and dark, and uniformly thick and well-defined
• 1.84(p)(3) — reference characters at least 0.32 cm (1/8 inch) high, so they survive reduction
• 1.84(u) — views numbered in consecutive Arabic numerals starting with 1, preceded by the abbreviation “FIG.”

The tell in a diligence review is not a single violation — it is a pattern. Faint lines and undersized reference characters together usually mean the figures were exported from CAD or a slide deck by someone who was not preparing patent drawings, and that the same shortcut was taken across the portfolio.

Ask directly whether any application has received a Notice of Draftsperson’s Patent Drawing Review. It is a formalities notice rather than a rejection on the merits, but it still consumes calendar time, and it tells you how the file was prepared. Our breakdown of the MPEP drawing requirements sets out how examiners apply these standards in practice.

Check 3: Do the Figures Support the Claims Under Section 112(a)?

Formalities are the cheap problem. Support is the expensive one. Under 35 U.S.C. 112(a), the specification must contain a written description of the invention and enable a person skilled in the art to make and use it. Drawings are part of the specification, and in mechanical, electrical and device cases they frequently carry most of the disclosure weight.

The question to ask is forward-looking: if this company needs to amend the claims later — in a continuation, in prosecution, or to survive an inter partes review — is there anything in the figures to amend toward? A file with detailed, well-differentiated figures has optionality. A file with three block diagrams does not.

This is where patent drawings for investors stop being a formality check and start being a valuation input. Disclosure you did not file cannot be added later; the prohibition on new matter is absolute. What is in the drawings on the filing date is the whole of what the company will ever be able to claim from that application.

Software and AI companies deserve particular attention here, because the figures are often flowcharts of the most generic kind. We cover what adequate disclosure looks like in that setting in patent drawings for software inventions.

Check 4: In a Design Portfolio, the Broken Lines Are the Claim

If the company holds design patents — common in consumer hardware, medical devices and interface-led products — the drawings are not evidence of the claim. They are the claim. 37 CFR 1.152 governs, and it is short enough to read in full during diligence.

The operative points: the design must be represented by a drawing complying with 1.84 and containing sufficient views to constitute a complete disclosure; appropriate and adequate surface shading should be used to show the character or contour of the surfaces; solid black surface shading is not permitted except to represent the color black or color contrast; and broken lines may be used to show visible environmental structure, but may not be used to show hidden planes and surfaces that cannot be seen through opaque materials.

That last one decides scope. Everything drawn in solid line is claimed; everything in broken line is disclaimed environment. A design patent that renders the entire product in solid line is narrow — a competitor avoids it by changing any visible feature. One that isolates the distinctive element in solid line and puts the rest in broken line is far harder to design around. Two filings that cost the same can differ enormously in what they actually cover, and the only way to see the difference is to look at the sheets.

Also check that photographs and ink drawings have not been combined in one application, and that any photographs do not disclose environmental structure — 1.152 prohibits both. Interface-heavy portfolios raise a further set of questions, which we address in GUI design patent drawings.

Check 5: Will the Same Figures Survive Europe and the PCT?

Most portfolios that matter to an investor are going abroad, so the figures have to work outside the United States. Here a point of law has changed recently enough that a lot of published guidance is now wrong.

Rule 46 EPC was the provision that set out the form of the drawings — sheet sizes, margins, line quality, reference signs. It was deleted with effect from 1 February 2023, together with Rule 49(3) to (12) EPC, as part of the EPO’s digital-transformation package. The presentation requirements did not disappear; they were moved into a Decision of the President of the EPO, with Rule 49 EPC as the enabling provision. The practical requirements are substantially similar, but the legal basis is different, and any adviser still citing Rule 46 EPC as live law has not refreshed their materials since 2022.

Two further European points belong in a diligence review. Colour is no longer categorically off the table at the EPO — the office now accepts colour drawings, a change we covered in EPO color patent drawings. And under Article 123(2) EPC, amendments may not extend beyond the content of the application as filed. Drawings count as part of that content, but the EPO applies a strict standard: a feature can be taken from a drawing only where it is directly and unambiguously derivable from it. Relative dimensions measured off a schematic figure will generally not provide a basis for amendment. Schematic figures are worth less in Europe than they look.

For the international phase, PCT Rule 11 sets the physical requirements for the international application, drawings included. A figure set built to 1.84 will usually be close, but “usually close” is how portfolios acquire rework costs at national-phase entry.

Check 6: Colour and Photographs Carry Procedural Risk

Colour and photographs are the two shortcuts that look efficient and are not. Under 1.84(a)(2), the USPTO accepts colour drawings in a utility application only after granting a petition — which means the fee under 1.17(h), the required sets of drawings, and an amendment to the specification. Every one of those is a step that can be missed, and a missed step is an office action.

Photographs sit differently. Under 1.84(b)(1), photographs — including photocopies of photographs — are not ordinarily permitted in utility and design applications, but they are acceptable where photographs are the only practicable medium for illustrating the claimed invention. That is a substantive test about the subject matter, not a formality the applicant can elect into. We work through when it is genuinely satisfied in photographs in patent applications.

In diligence, the flag is a portfolio that used photographs or colour for convenience — product shots dropped into a filing — rather than because the invention could not be shown in line drawings. It usually correlates with the rest of the file being prepared the same way.

Check 7: One Consistent Figure Set Across the Whole Family

The last check is the one that separates a managed portfolio from an accumulated one. Pull the parent, the continuations, the PCT application and any national-phase filings, and put the figure sets side by side. They should match, and the reference numerals should mean the same thing in every one.

Drift is common and it is diagnostic. It usually means different providers prepared different filings, or that figures were re-exported for a foreign filing without anyone reconciling them against the parent. The consequences are real: inconsistent numerals invite objections, and a divergent figure set complicates any argument that a later claim was supported by the original disclosure.

When you review patent drawings for investors across a family rather than one application at a time, you are really assessing whether the company has a prosecution process. Families whose figures are identical across jurisdictions were managed. Families whose figures drift were not, and the same absence of process is usually visible in their docketing and their deadlines.

1. Confirm the figure count and view numbering match across the family
2. Confirm each reference numeral labels the same element in every filing
3. Confirm foreign-filed sheets were prepared to the destination office’s requirements, not simply reprinted
4. Confirm any drawing amendment made in one member was mirrored where it should have been

Running the Review in an Afternoon

None of this requires a full freedom-to-operate exercise. For a seed or Series A portfolio of five to fifteen families, the seven checks take an afternoon, and they can be run from the published applications and the file wrappers without any cooperation from the company.

The order matters. Do Check 1 first, because it is the fastest and the most likely to fail. Do Check 4 next if there are design filings, because scope errors there are the least recoverable. Formalities can wait — they cost time, not rights.

What you are buying with the afternoon is a calibrated view of two numbers the company has already given you: how long until these applications issue, and how much of the product they cover. In our experience reviewing patent drawings for investors, those two numbers are the ones most often wrong in a data room, and the figures are where the error is visible.

How PerspireIP Can Help

PerspireIP prepares USPTO, EPO and PCT-compliant figures and reviews existing drawing sets for the defects above. Our patent drawing services cover utility and design figures, replacement sheets for files already under objection, and family-wide consistency reviews for portfolios heading into a financing or an acquisition.

If you are assessing patent drawings for investors ahead of a round, or you are the company that would rather find these problems before a diligence team does, talk to us. We will tell you what the figures actually say.

Frequently Asked Questions